Your browser doesn't support javascript.
loading
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma.
Zengin, Zeynep B; Govindarajan, Ameish; Salgia, Nicholas; Sayegh, Nicolas; Tripathi, Nishita; Muddasani, Ramya; Chehrazi-Raffle, Alex; Feng, Matthew; Mercier, Benjamin D; Ladbury, Colton; Hao, Claire; Salgia, Sabrina; Chawla, Neal; Meza, Luis; Malhotra, Jasnoor; Dizman, Nazli; Hsu, JoAnn; Castro, Daniela V; Barragan-Carrillo, Regina; Ebrahimi, Hedyeh; Philip, Errol J; Chang, Mark; Zhang, Jiaming; Byron, Sara; Lyou, Yung; Dorff, Tanya; Pal, Sumanta K; Dandapani, Savita.
Afiliação
  • Zengin ZB; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Govindarajan A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Salgia N; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Sayegh N; Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Tripathi N; Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Muddasani R; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Chehrazi-Raffle A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Feng M; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Mercier BD; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Ladbury C; Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Hao C; Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Salgia S; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Chawla N; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Meza L; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Malhotra J; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Dizman N; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Hsu J; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Castro DV; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Barragan-Carrillo R; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Ebrahimi H; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Philip EJ; University of California-San Francisco, San Francisco, CA, USA.
  • Chang M; Kerk Kerkorian School of Medicine at UNLV, Las Vegas, NV, USA.
  • Zhang J; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Byron S; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Lyou Y; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Dorff T; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Pal SK; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: spal@coh.org.
  • Dandapani S; Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: sdandapani@coh.org.
Eur Urol Oncol ; 6(4): 447-450, 2023 08.
Article em En | MEDLINE | ID: mdl-36609061
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Radiocirurgia / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Radiocirurgia / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos